ANTI-MÜLLERIAN HORMONE (AMH)
Anti-Müllerian hormone (AMH) is a unique reproductive hormone produced by granulosa cells of small growing follicles in the ovary. It plays a central role in ovarian physiology by regulating follicle recruitment, influencing ovarian reserve and serving as a key biomarker in fertility assessment. AMH is particularly valuable clinically because its levels remain relatively stable across the menstrual cycle, allowing reliable measurement at any time. Beyond its importance in female reproduction, AMH also plays a crucial prenatal role in sexual differentiation in males, where it drives regression of the Müllerian ducts during fetal development. Understanding AMH provides essential insight into follicular dynamics, fertility, ovarian ageing and disorders such as PCOS and premature ovarian insufficiency.
What You Need to Know
Anti-Müllerian hormone is a glycoprotein hormone with important roles in reproductive development and function in both females and males. Its significance differs by sex and life stage, but in all contexts it reflects regulation of reproductive structure and capacity rather than moment-to-moment cycle control.
In females, AMH is produced by granulosa cells of pre-antral and small antral follicles. Because these follicles represent the pool that is actively growing but not yet selected for dominance, circulating AMH provides a stable reflection of ovarian reserve. AMH levels are relatively constant across the menstrual cycle, peak in early adulthood, and decline progressively with age until becoming very low or undetectable around menopause. Importantly, AMH reflects the quantity of remaining follicles rather than their genetic or functional quality.
AMH also has a local regulatory role within the ovary. It limits the rate at which primordial follicles are recruited into growth, preventing excessive depletion of the ovarian reserve and helping to pace folliculogenesis over the reproductive lifespan. Key features of AMH physiology include:
Production by small growing follicles, linking levels to ovarian reserve
Inhibition of early follicle recruitment, protecting the finite follicle pool
Relative cycle stability, making AMH less variable than FSH or estradiol
Age-related decline, reflecting natural ovarian ageing rather than acute dysfunction
In males, AMH has a critical developmental role rather than a reproductive one in adulthood. During fetal life, Sertoli cells of the developing testes secrete large amounts of AMH, which induces regression of the Müllerian ducts. This prevents formation of the uterus, fallopian tubes, and upper vagina, allowing normal male internal reproductive development. AMH levels are high in male infancy and childhood and decline at puberty as testosterone production increases and Sertoli cell function matures.
Together, these roles position AMH as a marker of reproductive potential in females and a determinant of sex differentiation in males. Understanding its function helps distinguish ovarian reserve from ovulatory function, clarifies differences between quantity and quality of follicles, and explains why AMH is informative across the lifespan rather than within a single menstrual cycle.
Beyond the Basics
Ovarian AMH Production and Follicle Dynamics
AMH secretion begins when primordial follicles are recruited into the growing pool and is highest in pre-antral and early antral follicles. As follicles continue to mature and approach dominance, AMH expression falls sharply and is minimal in pre-ovulatory follicles. This pattern reflects AMH’s role as a regulator of early follicular activity rather than later stages of ovulation.
By inhibiting excessive recruitment of resting primordial follicles, AMH helps distribute follicle activation gradually across the reproductive lifespan. It also reduces the sensitivity of growing follicles to follicle-stimulating hormone, preventing premature acceleration of follicle growth. Through these combined actions, AMH functions as a governor of follicular economy, slowing depletion of the ovarian reserve and supporting long-term reproductive potential.
AMH and Ovarian Reserve Assessment
Because circulating AMH levels closely mirror the number of small growing follicles, they provide a practical estimate of ovarian reserve. Unlike FSH or estradiol, which vary significantly across the menstrual cycle and are influenced by short-term endocrine feedback, AMH remains relatively stable. This stability makes it particularly useful in fertility assessment and longitudinal monitoring.
Low AMH levels indicate a reduced pool of recruitable follicles and are commonly observed with advancing reproductive age or premature ovarian insufficiency. In contrast, elevated AMH levels are characteristic of polycystic ovary syndrome, reflecting the accumulation of small antral follicles rather than enhanced ovulatory capacity. This distinction explains why high AMH does not equate to increased fertility and must be interpreted in clinical context.
AMH in Male Fetal Development
In males, AMH plays a pivotal developmental role rather than a regulatory one in adult reproduction. Sertoli cells begin secreting large amounts of AMH early in fetal life, before testosterone-driven differentiation occurs. This early secretion induces regression of the Müllerian ducts, preventing development of female internal reproductive structures.
AMH therefore acts as one of the earliest indicators of functional testicular tissue in embryonic development. After birth, AMH levels remain high throughout childhood and decline during puberty as Sertoli cells mature and intratesticular testosterone rises, shifting testicular function toward spermatogenesis.
Receptors and Mechanisms of Action
AMH exerts its effects through the AMH type II receptor (AMHR2), which is expressed in ovarian granulosa cells and Müllerian duct derivatives. Activation of this receptor initiates intracellular signalling pathways that alter gene expression and cellular differentiation. Within the ovary, AMH signalling modulates follicular responsiveness to FSH and influences the pace of follicle maturation rather than triggering ovulation itself.
Understanding these receptor-level actions helps explain why AMH levels reflect the size and behaviour of the follicle pool, rather than short-term hormonal fluctuations seen across the menstrual cycle. AMH is produced by small growing follicles, so its levels remain relatively stable and are not significantly influenced by acute endocrine changes. For this reason, AMH occupies a unique position among reproductive hormones, acting as a marker of ovarian reserve and reproductive lifespan, rather than indicating cycle phase or immediate hormonal status.
Clinical Connections
AMH testing is widely used in reproductive medicine because it provides insight into ovarian reserve and expected ovarian response without being tied to a specific cycle day. Its value lies in predicting how the ovaries are likely to respond, rather than whether ovulation or pregnancy will occur naturally. Interpretation always requires clinical context, as AMH reflects follicle quantity rather than oocyte quality or endocrine balance.
In practice, AMH informs several key clinical decisions:
IVF and ovulation induction, where AMH helps guide gonadotrophin dosing and predict ovarian response
Risk stratification for ovarian hyperstimulation syndrome, particularly in individuals with high AMH
Assessment of diminished ovarian reserve, including premature ovarian insufficiency
Evaluation of PCOS, where elevated AMH reflects increased small follicle numbers and contributes to altered follicular sensitivity to FSH
Low AMH levels are associated with a reduced response to ovarian stimulation and fewer retrievable oocytes during assisted reproduction, although pregnancy remains possible. Very low or undetectable AMH may indicate premature ovarian insufficiency or gonadal dysgenesis, particularly when accompanied by menstrual disturbance or elevated gonadotrophins. In contrast, high AMH in PCOS reflects accumulation of small follicles rather than enhanced fertility and is linked to disrupted follicular progression and anovulation.
In males, AMH measurement has diagnostic value in early life rather than adult fertility assessment. It assists in evaluating disorders of sex development, particularly in infants with ambiguous genitalia. Detectable AMH suggests functional Sertoli cells and testicular tissue, helping differentiate undescended testes from anorchia. Rare mutations in AMH or its receptor (AMHR2) result in persistent Müllerian duct syndrome, where Müllerian structures persist despite otherwise typical male internal and external genital development.
Overall, AMH serves as a marker of reproductive potential and developmental integrity rather than active reproductive function. Its clinical utility lies in guiding investigation, counselling, and treatment planning rather than acting as a standalone predictor of fertility.
Concept Check
Why is AMH considered one of the most reliable indicators of ovarian reserve?
Which follicles produce AMH, and why does production decline as follicles mature?
How does AMH help regulate the rate of follicular recruitment and FSH sensitivity?
What does elevated AMH typically suggest in conditions such as PCOS?
What role does AMH play in male fetal development?